════════════════════════════════════════════════════════
  PORTFOLIO MANAGEMENT BRIEFING — 2026-11-03
════════════════════════════════════════════════════════
Portfolio management exercise — not financial advice. Confirm independently before trading.

Run context: Tuesday 23:30 slot (started 23:40 CET). This is a separate full run; the last briefing was Monday night's
(written 11-03 00:01).
Turso check: no new trades or cash_ledger entries for trading-portfolio since 10-01.
Pipeline health: OK, all tracked tasks are healthy.
Prices: Turso holds Mon 11-02 closes for US names and Fri 10-30 for UK/EU (refresh-technicals runs 07:17). This run uses
**Tue 11-03 closes from a direct yfinance pull** for every holding, with RSI/MACD/SMA50/ATR recomputed. The one
exception is ZOE, which has no Yahoo data, so it's carried at the 10-30 Turso quote (€72.00). ACN uses its Xetra
listing (CSA.DE). FX: EUR/USD 1.1192, GBP/EUR 1.1981.
Options: all three are marked with Black-Scholes on Tuesday closes (r 4%). ORCL uses 61.7% vol and PLTR 64.3%, the vols
options_pricing.py used last. NBIS is a hand estimate at 80% vol, because its Turso row still has no strike.
Data quality: check_data_quality.py was started in the background and had produced no output by the time this was
written (the same pattern as previous nights). Known repeats affecting holdings: ACN/ZOE EU fundamentals, QXO-PB
fundamentals and the NBIS option_mark row (no strike). None of them changes a figure here.

PORTFOLIO SNAPSHOT
  Positions:        21 open (17 long equity, 1 short, 3 options)
  Total Value:      ~€21,159 (estimated: long equity €17,282 + options ~€1,855 + ORCL short unrealized +€127 + cash €1,895)
                    −€500 vs Monday's €21,659. Most of it is the bearish overlay giving back Monday's gain: **ORCL +5.9%
                    to $126.19** and **NBIS +7.3% to $151.64** cut the puts by ~€356 (ORCL put −€264, NBIS put −€123,
                    PLTR put +€30), and the ORCL short gave back ~€31. Long equity fell €113: **SFM −5.0%**, FLUT −4.5%,
                    WKL −2.3%, ACN −2.1%, ADBE −2.1%, SAP −1.8%, REL −1.5%. ERO +4.4% and IQV +1.6% moved the other way.
  Available Cap:    €1,895.31 cash
  Best Performer:   ACN +61.5% (IQV +60.2%, SAP +51.2%)
  Worst Performer:  SFM −34.5% (PRX −14.1%, ERO −12.5%, EDEN −9.7%)
  Largest Position: LULU (10.0% of long book; GSK 8.9%, SAP 8.4%, REL 8.2%, ACN 7.9%)
  FX:               EUR/USD 1.1192 | GBP/EUR 1.1981 | Prices are Tue 11-03 closes (ZOE carried from 10-30)

POSITION SIGNALS
  ┌──────────┬────────────┬─────────┬───────┬──────────┬───────────────────┬─────┐
  │ Ticker   │ P&L%       │ RSI(14) │ vs50d │ Signal   │ Catalyst          │ MF# │
  ├──────────┼────────────┼─────────┼───────┼──────────┼───────────────────┼─────┤
  │ ACN      │ +61.5%     │ 69.3    │ ↑     │ Hold     │ FR ✓ (execute)    │ 77  │
  │ IQV      │ +60.2%     │ 45.8    │ ↓     │ Watch    │ free-ridden       │ 701 │
  │ SAP      │ +51.2%     │ 58.4    │ ↑     │ Watch    │ MACD turned bear  │ 425 │
  │ KLR      │ +35.5%     │ 56.1    │ ↑     │ Hold     │ free-ridden       │ 57  │
  │ WKL      │ +20.5%     │ 64.3    │ ↑     │ Watch    │ MACD turned bear  │ 146 │
  │ REL      │ +14.2%     │ 62.2    │ ↑     │ Watch    │ MACD bearish      │ 288 │
  │ ZOE      │ +13.9%     │ 67.3*   │ ↑     │ Hold     │ *10-30, no Yahoo  │ —   │
  │ BIRK     │ +10.8%     │ 60.3    │ ↑     │ Hold     │ —                 │ 268 │
  │ ADBE     │ −1.5%      │ 47.2    │ ↓     │ Watch    │ MACD turned bear  │ 23  │
  │ LULU     │ −5.2%      │ 58.0    │ ↑     │ Hold     │ ATR stop ~$101    │ 35  │
  │ GSK      │ −5.8%      │ 47.3    │ ↓     │ Watch    │ stop ref ~1,748p  │ 47  │
  │ QXO-PB   │ −6.8%      │ 46.8    │ ↓     │ Watch    │ stop ref ~$33.36  │ —   │
  │ FLUT     │ −9.0%      │ 53.7    │ ↓     │ Watch    │ Earnings 11-12    │ —   │
  │ EDEN     │ −9.7%      │ 28.2    │ ↓     │ EXIT     │ Exit day 9; <floor│ —   │
  │ ERO      │ −12.5%     │ 40.0    │ ↓     │ Watch    │ <$31.50 stop ref  │ 71  │
  │ PRX      │ −14.1%     │ 50.9    │ ↓     │ Watch    │ exit < €33.03     │ 596 │
  │ SFM      │ −34.5%     │ 34.3    │ ↓     │ EXIT     │ bounce faded      │ 132 │
  │ ORCL (S) │ +18.4%     │ 44.2    │ ↓     │ Hold     │ stop ref ~$138.2  │ 619 │
  └──────────┴────────────┴─────────┴───────┴──────────┴───────────────────┴─────┘
  P&L% uses the reconciled real fills from the wiki (KLR 2,400p, WKL €70.88, IQV $163.91, PRX €41.065, FLUT $92.02), not
  Turso's older entry prices. TA is recomputed from Tuesday closes, not Turso's rows.
  MF# is the full-universe rank, unchanged from Monday. EDEN, ZOE, FLUT and QXO-PB have no rank. ACN's rank is from its
  US listing.
  ORCL (S) P&L is the short's gain on entry ($154.552 → $126.19).
  Signal changes vs Monday:
  - **ERO: Exit → Watch, by a hair.** +4.4% to $30.44 put RSI at 40.004, just above the <40 Exit line. It's still below
    SMA50 ($35.11) with a bearish MACD, and **still $1.06 below the $31.50 stop ref**, so the exit recommendation stands
    on the stop, not the mechanical signal.
  - **SAP: Hold → Watch.** −1.8% to €206.65 and the MACD crossed bearish. RSI 58.4, still 7.5% above SMA50 (€192.20).
    The free ride no longer covers cost after tax (see below).
  - **WKL: Hold → Watch.** −2.3% to €85.44, MACD turned bearish, RSI 64.3. Still 15.5% above SMA50 (€73.97).
  - **FLUT: Hold → Watch.** −4.5% to $83.74, back below SMA50 ($86.39), ahead of its 11-12 report.
  - **ADBE: still Watch, MACD now bearish too.** −2.1% to $246.14, RSI 47.2, below SMA50 ($253.29). An RSI print under
    40 would make it a mechanical Exit.
  - **SFM's bounce faded.** −5.0% to $52.49 (RSI 34.3), giving back ~half of Monday's +11.1%. Still a mechanical Exit.
  - **IQV steadied.** +1.6% to $262.59, RSI 45.8 (from 41.8), still $3.5 below SMA50 with a bearish MACD.
  - **ORCL short: +5.9% bounce to $126.19**, RSI 44.2, MACD bearish, still $14.7 below SMA50. +$142 (+18.4%), down from
    +$177. The price-based stop ref is ~$138.2.

PORTFOLIO SHAPE
  Concentration:   OK — no position ≥25% (largest LULU 10.0%)
  Sector spread:   Tech/Software (SAP, ACN, ADBE) 22.6% | Healthcare (GSK, ZOE, IQV) 19.2% | Consumer (LULU, SFM, BIRK) 17.3% |
                   Info services (REL, WKL) 15.6% | Industrials (QXO-PB, KLR) 7.8% | Fintech EDEN 6.2% | Internet/SOTP PRX 6.1% |
                   Materials ERO 4.7% | iGaming FLUT 0.4%
                   No sector is above 25%. Executing the three exit recommendations (EDEN, ERO, SFM, 13.6% of the book
                   together) would lift Tech/Software to ~26% of the remaining long book; the ACN free ride (4 shares,
                   ~€912 gross) would bring it back to ~21%.
  Currency split:  EUR 42.3% | USD 38.4% | GBp 19.3% (long book)

TODAY'S TRADE IDEAS
  ── SELLS / TRIMS ──────────────────────────────────────
  SFM: Full Exit (mechanical Exit, day 4; the $60.85 hard stop broke on the 10-29 post-Q3 gap). $52.49 after Tuesday's
    −5.0%, RSI 34.3, below SMA50 $68.49, MACD bearish. Monday's bounce wasn't sold and has already halved.
  Expected proceeds: ~$525 (~€469). Realized loss ≈ −$277 (≈ −€247) plus ~€4.47 commission, so no CGT.

  EDEN: Full Exit (mechanical Exit, day 9, **7.1% below the €25.77 patience floor**). €23.95, RSI 28.2, below SMA50
    €27.96, MACD bearish.
  Expected proceeds: ~€1,078. Realized loss ≈ −€116 against the €1,193.85 cost, plus ~€4.47 commission, so no CGT.

  ERO: Full Exit on the stop (the mechanical Exit cleared by 0.004 RSI points today, but it's **$1.06 below the $31.50
    stop ref** for the 4th session). $30.44, below SMA50 $35.11, MACD bearish.
  Expected proceeds: ~$913 (~€816). Realized loss ≈ −$131 (≈ −€117) plus ~€4.47 commission, so no CGT. If you'd rather
    hold for the signal, the alternative is: exit on a close back above $31.50 failing, or on RSI < 40 again.

  ORCL put: **Close — Monday's own hold condition has now triggered.** ORCL closed at $126.19, above the ~$126 (October
    low) line set in the 11-02 briefing. The $120 Dec put is back $6.19 out of the money and marked ~$7.54/sh (~€674)
    against €982 cost (~69% of premium, down from ~96% yesterday). 45 days left and theta is accelerating. The 5-share
    short keeps the bearish ORCL view on. Not a mechanical signal; the alternative is to hold the full premium at risk
    into expiry.
  No Trim signals. No position is ≥20% weight, so the Trim rule can't fire. The ACN free ride is below.

  ── ADDS TO EXISTING ───────────────────────────────────
  No Add signals. Nothing is RSI 35–50 above SMA50 with a bullish MACD. IQV, GSK, ADBE and QXO-PB are in the RSI band but
  below SMA50, which makes them Watch, not Add.

  ── NEW POSITIONS ──────────────────────────────────────
  MONY:  Enter on a dip to ~200p (Tue close 205.4p, RSI 65.3) — Turso screen 5/5, MF#22
         Stop: 189.5p | Size: €750
  APA:   Enter at ~$47.77 (Tue close, −2.2%, RSI 48.7) — Turso screen 5/5, MF#51
         Stop: $45.17 | Size: €750 (starter: MACD crossed bearish today)
  BAMNB: Enter on a pullback to ~€12.40 (Tue close €12.71, RSI 65.6) — Turso screen 5/5, MF#36
         Stop: €11.85 | Size: €750
  Cash is €1,895 before exit proceeds (~€2,363 more if all three exits are executed, ~€834 net more from the ACN free
  ride, ~€674 from closing the ORCL put). MONY already had an active Pending Trade Idea card (dedup skipped it); APA and
  BAMNB are new cards. BBW and CF dropped off the Turso screen today and weren't carried forward; their existing cards
  stay in the queue until approved, rejected or expired.

INVESTMENT OPPORTUNITIES
  5/5 · MONY (FTSE350, Communication Services — MONY Group) — Magic Formula pass, P/E 13.0, EY 11.0%, ROIC 33.6% | MF#22
  Entry: ~200p limit (Tue close 205.4p) | Stop: 189.5p (1.5×ATR 7.0p) | Size: €750 | RSI: 65.3 | MACD: Bullish
  Conviction: MF#22; Magic Formula pass; corroborated by briefing-recommendation; bullish MACD.
  Portfolio fit: adds a new sector (Comms) and GBp exposure. 6.7% above SMA50 (192.6p) and above the 200-day (181.3p), in
    a clean uptrend. Still the best-ranked name on the screen.

  5/5 · APA (S&P 500, Energy — APA Corp) — Magic Formula pass, P/E 11.2, EY 15.6%, ROIC 18.5%, yield 1.9% | MF#51
  Entry: ~$47.77 (current) | Stop: $45.17 (1.5×ATR $1.73) | Size: €750 | RSI: 48.7 | MACD: Bearish (crossed 11-03)
  Conviction: MF#51; Magic Formula pass; corroborated by briefing-recommendation (Turso screen still shows Monday's
    bullish MACD).
  Portfolio fit: adds Energy, a sector the book doesn't hold, in USD. 4.4% above SMA50 ($45.76) and well above the
    200-day ($38.65). Tuesday's MACD cross is why this is a starter; waiting for the MACD to turn back is the more
    patient entry.

  5/5 · BAMNB (STOXX600, Industrials — Royal BAM Group) — Magic Formula pass, P/E 13.6, EY 10.4%, ROIC 31.2% | MF#36
  Entry: ~€12.40 limit (Tue close €12.71) | Stop: €11.85 (1.5×ATR €0.37) | Size: €750 | RSI: 65.6 | MACD: Bullish
  Conviction: MF#36; Magic Formula pass; bullish MACD (uncorroborated — no second signal yet).
  Portfolio fit: Industrials is 7.8% of the book (QXO-PB, KLR), so there's room; adds EUR. 7.6% above SMA50 (€11.81) and
    above the 200-day (€10.72); RSI above 65, so buy a pullback rather than chase.

  Also considered: **TMV (5/5) fell −26.8% today to €5.29 (RSI 23.5)**, so it's out — the screen's 10-30 data doesn't
    reflect it yet. DNLM (5/5, exited in Sept at a loss), EQNR and REP (5/5, Energy overlaps APA; EQNR MACD bearish),
    BMY (5/5, below SMA50; adds to Healthcare at 19%), AUTO and MO (4/5, no MF pass).

FREE RIDE OPPORTUNITIES
  ACN: Sell 4 of 6 shares at €227.90 → ~€912 gross proceeds covers the cost basis (€846.60)
  Free position: 2 shares at zero effective cost | Current value: ~€456
  After CGT (€72.91 on €347.20 gain) and commission (~€4.47), net cash is ~€834, **€12 short of cost after tax** (it
  was +€3 on Monday). The after-tax break-even is ~€231.82.
  Status: **Execute now (recommended).** RSI 69.3 is close to overbought and the price is 26% above SMA50 (€181.13).
    The gross-proceeds test still passes above ~€211.65.

  SAP: Sell 5 of 7 shares at €206.65 → ~€1,033 gross proceeds covers the cost basis (€956.90)
  Free position: 2 shares at zero effective cost | Current value: ~€413
  After CGT (€73.45 on €349.75 gain) and commission (~€4.47), net cash is ~€955, **€2 short of cost after tax**. The
  after-tax break-even is ~€207.05.
  Status: **Monitor.** RSI fell to 58.4 and the MACD turned bearish, so the "RSI > 65" condition for executing no longer
    holds. Re-check on the next RSI extension; the gross test passes above ~€191.40.

  IQV: ✅ Already free-ridden. All 3 remaining shares are held at zero effective cost (current value ~€704).
  KLR: ✅ Already free-ridden. All 10 remaining shares are held at zero effective cost (current value ~€390).
  WKL (+20.5%) and REL (+14.2%) are below the 25% threshold. WKL would qualify (sell 13 keep 2) above ~€88.60.

PORTFOLIO RISKS TO WATCH
  - Three positions carry exit recommendations (EDEN day 9, SFM day 4, ERO on the stop), together ~€2,363 at a combined
    realized loss of ≈ −€480. SFM's Monday bounce has already half-faded; waiting has cost money on all three.
  - The trend is weakening broadly. Below SMA50 now: IQV, GSK, ADBE, FLUT, QXO-PB, PRX plus EDEN, SFM and ERO (~45% of
    the long book, up from ~44%). SAP, WKL, REL and ADBE all have bearish MACDs.
  - The bearish overlay gave back ~€387 in one session (puts −€356, short −€31) on ORCL/NBIS rebounds. The ORCL put is
    now $6.19 OTM with 45 days left; the hold condition set yesterday has triggered.
  - No stop orders are in place on any position. FLUT reports 11-12.
  - Data: the NBIS put is still marked by hand (its Turso row has no strike, expiry or type). ZOE has no Yahoo price
    feed, so its TA here is carried from 10-30. The Turso candidate screen still prices UK/EU names at 10-30 (TMV's
    −26.8% isn't in it).

NEXT ACTIONS
  1. SFM: execute the Full Exit (~$525 / ~€469, ≈ −€247).
  2. EDEN: execute the Full Exit (~€1,078, ≈ −€116). Day 9 of Exit and 7.1% below the €25.77 floor.
  3. ERO: execute the Full Exit on the $31.50 stop (~€816, ≈ −€117).
  4. ORCL put: close it (~€674, −€308 vs cost). ORCL closed above the ~$126 line the 11-02 briefing set.
  5. ACN: execute the 4-share free ride (~€834 net, 2 shares free). It's €12 short of cost after tax, but RSI 69.3 and
     26% above SMA50.
  6. SAP: monitor the free ride; execute on the next RSI push above 65 while the price is above ~€207.
  7. LULU: patience override retired per Monday's review; use an ATR stop of ~$101 (1.5×ATR below $106.95).
  8. IQV: if RSI closes below 40 (mechanical Exit), sell the 3 free shares (~$788). GSK: set a real stop at ~1,748p.
  9. Optional entries: MONY at ~200p and BAMNB at ~€12.40 (limits), APA at ~$47.77 (€750 starters each). Approve or
     reject them in the Pending Trade Ideas panel.
  10. Fill in the NBIS put's strike, expiry and type in Turso so options_pricing.py can mark it.
════════════════════════════════════════════════════════
